Cannabidiol (CBD) is a compound found in cannabis plants that has been gaining attention for its potential therapeutic benefits. Recent studies have suggested that CBD may be effective in treating a variety of mental health conditions, including anxiety and depression. In this article, we'll explore the evidence for CBD's psychological effects and discuss the potential risks associated with its use. A placebo-controlled study conducted by Crippa et al showed a decrease in symptoms of social anxiety, but also in sedation, in a small group of 10 patients who received CBD. This suggests that CBD may be an effective treatment for social anxiety and other anxiety disorders.
However, it is important to note that this study was conducted on a very small sample size and more research is needed to confirm these findings. The FDA has even approved the use of cannabidiol in the treatment of epilepsy. A recent clinical trial has shown that CBD can effectively reduce anxiety. The form consisted of 5 separate pages: consent for the study, questions about demographics, questions about previous psychiatric treatment, questions about the use of CBD and the HADS questionnaire. The researchers found that a 300 mg dose of CBD was the most effective in significantly reducing anxiety during the test (1).CBD products have been products of interest in the treatment of social anxiety and anxiety disorders.
Low-quality CBD products, which may contain THC or with a composition that does not match the descriptions on the label, are widespread on the market and it is clear that there is an unmet need for high-quality products and new effective treatments. An important element in the mystery of the CBD phenomenon is the chemical composition of the oil itself (or of the nuts you buy). Little or no effect was reported in people who took the placebo, a 150 mg dose of CBD, or a 600 mg dose of CBD (1).CBD is commonly used to control psychiatric symptoms. However, recent evidence has shown that up to 50% of psychiatric patients who consume CBD do not report it to their doctors3, which highlights the perceived effectiveness of CBD by consumers and the possible risks of unregulated and poor quality CBD. Our goal was to explore the basic demographic and epidemiological characteristics of people who use CBD to self-treat their depressive disorders and to demonstrate the fact that this phenomenon exists. Most of the respondents were or are still being treated by a psychiatrist (55%) and started using CBD to treat depressive mood (69%).At the same time, in the group of psychiatric patients, only 49% of those surveyed informed their psychiatrist about the use of CBD during psychiatric treatment.
This situation is potentially dangerous because when patients buy CBD outside the pharmacy, this sale escapes the control of the pharmaceutical regulatory authority, which can encourage the accidental ingestion of other substances than expected, since when sales are outside the control of pharmaceutical regulators, consumers must trust the honesty of sellers. However, under certain conditions, CBD can be dangerous, since it is metabolized in the liver with the participation of CYP3A4, affecting its interactions with many drugs that are also processed with the participation of this enzyme system (including antifungals, clarithromycin or rifampicin) (. Self-medication with CBD or other supplements may cause treatment delays, which may cause symptoms to worsen).CBD is added to foods, beverages, dietary supplements, and body care products, and these items are often marketed as a way to improve stress, pain, and sleep problems. Some research suggests that CBD may be effective for certain types of pain, such as nerve pain and back pain, when used alone. With more than 70 years of experience in the production and supply of quality APIs, along with unique specialized services and customized solutions, DSM is the ideal partner for the development of purpose-oriented CBD-based pharmaceutical products that can contribute to the mental health and well-being of patients on a global scale.